LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

21.48 0.8

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

21.3

Max

21.78

Belangrijke statistieken
By Trading Economics
Inkomsten	2M -17M
Verkoop	178K 264K
EPS	-0.257
Winstmarge	-6,603.409
Werknemers	116
EBITDA	2M -17M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+40.85% upside

Dividenden
By Dow Jones
Volgende Winsten	7 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	20.68
Vorige sluitingsprijs	21.48

Nieuwssentiment

By Acuity

41%

59%

121 / 351 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

13 mrt 2026, 19:08 UTC

Belangrijke Nieuwsgebeurtenissen

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13 mrt 2026, 18:48 UTC

Winsten

Belangrijke Marktbewegers

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13 mrt 2026, 17:10 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13 mrt 2026, 17:10 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13 mrt 2026, 16:47 UTC

Belangrijke Nieuwsgebeurtenissen

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

13 mrt 2026, 22:27 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mrt 2026, 22:13 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mrt 2026, 22:04 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mrt 2026, 22:00 UTC

Acquisities, Fusies, Overnames

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

13 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

13 mrt 2026, 20:02 UTC

Marktinformatie

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mrt 2026, 19:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mrt 2026, 19:35 UTC

Belangrijke Nieuwsgebeurtenissen

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13 mrt 2026, 19:00 UTC

Marktinformatie

U.S. Natural Gas Futures Settle Lower -- Market Talk

13 mrt 2026, 18:49 UTC

Belangrijke Nieuwsgebeurtenissen

The Iran War Could Upend AI. Here's How. -- Barrons.com

13 mrt 2026, 18:24 UTC

Belangrijke Nieuwsgebeurtenissen

Impact of Middle East Conflict on TotalEnergies Activities

13 mrt 2026, 18:00 UTC

Belangrijke Nieuwsgebeurtenissen

Is War Good For the Economy? -- WSJ

13 mrt 2026, 17:23 UTC

Marktinformatie

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13 mrt 2026, 16:46 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13 mrt 2026, 16:38 UTC

Belangrijke Nieuwsgebeurtenissen

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13 mrt 2026, 16:34 UTC

Acquisities, Fusies, Overnames

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13 mrt 2026, 16:33 UTC

Acquisities, Fusies, Overnames

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13 mrt 2026, 16:32 UTC

Acquisities, Fusies, Overnames

EQT Completes Exit From Galderma

13 mrt 2026, 16:20 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

13 mrt 2026, 16:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

13 mrt 2026, 16:15 UTC

Belangrijke Nieuwsgebeurtenissen

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

13 mrt 2026, 16:11 UTC

Marktinformatie

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

13 mrt 2026, 16:00 UTC

Belangrijke Nieuwsgebeurtenissen

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

13 mrt 2026, 15:48 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

40.85% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 30 USD 40.85%

Hoogste 30 USD

Laagste 30 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

Buy

Hold

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

121 / 351 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.